CORVEL CORP·4

May 27, 8:14 PM ET

Yoss Jennifer 4

4 · CORVEL CORP · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

CORVEL (CRVL) VP Jennifer Yoss Exercises Options, Sells Shares

What Happened

  • Jennifer Yoss, Vice President of Accounting at CorVel Corp (CRVL), exercised stock options on May 26, 2026 to acquire 1,999 shares and sold those shares in open-market transactions the same day. She paid $101,812 in aggregate exercise costs (three exercises at $52.00, $52.00 and $49.63) and received aggregate sale proceeds of $121,980 (1,999 shares sold at $61.02), netting roughly $20,168 before fees and taxes. The filing shows related derivative dispositions at $0.00, reflecting conversion of the options into common shares.

Key Details

  • Transaction date: 2026-05-26 (Form 4 filed 2026-05-27 — appears timely)
  • Exercises (Acquired): 958 @ $52.00; 141 @ $52.00; 900 @ $49.63 — total 1,999 shares; total exercise cost $101,812.
  • Sales (Disposed): 958 @ $61.02; 141 @ $61.02; 900 @ $61.02 — total 1,999 shares; total proceeds $121,980.
  • Derivative-type entries showing $0.00 disposed correspond to the options being converted (M = option exercise).
  • Shares owned after the transactions: not reported in the excerpt provided.
  • Footnotes: F1 — standard time-based vesting (25% after one year, then 36 monthly installments). F2 — certain options vest based on achievement of performance criteria tied to earnings growth.

Context

  • This was an exercise followed by same-day sale (a cashless or sell-to-open pattern), which is common when insiders exercise options to cover exercise costs and tax obligations. These transactions are routine insider liquidity events and do not, by themselves, indicate management’s view on the company’s prospects.

Insider Transaction Report

Form 4
Period: 2026-05-26
Yoss Jennifer
Vice President of Accounting
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-26$52.00/sh+958$49,8133,131 total
  • Sale

    Common Stock

    2026-05-26$61.02/sh958$58,4582,173 total
  • Exercise/Conversion

    Common Stock

    2026-05-26$52.00/sh+141$7,3322,314 total
  • Sale

    Common Stock

    2026-05-26$61.02/sh141$8,6042,173 total
  • Exercise/Conversion

    Common Stock

    2026-05-26$49.63/sh+900$44,6673,073 total
  • Sale

    Common Stock

    2026-05-26$61.02/sh900$54,9182,173 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F1]
    2026-05-269000 total
    Exercise: $49.63Exp: 2027-05-12Common Stock (900 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F2]
    2026-05-269582,241 total
    Exercise: $52.00Exp: 2027-11-03Common Stock (958 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F2]
    2026-05-261412,100 total
    Exercise: $52.00Exp: 2027-11-03Common Stock (141 underlying)
Footnotes (2)
  • [F1]Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.
  • [F2]Option will vest based on achievement of certain performance criteria relating to earnings growth.
Signature
By: Sharon O'Connor For: Jennifer Yoss|2026-05-27

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT